Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$270.68
▲ $1.51 (+0.56%) today
Markets closed · 10:12pm ET

Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
80%
EPS beat rate
+2.58%
Avg. EPS surprise
Consecutive EPS beats
JNJ vs Market · 30-day return after each reportJNJS&P 500
0%+5%+10%−1.5%+10.5%Q1 25+7.2%+3.1%Q2 25+2.3%+1.5%Q3 25+12.8%−0.4%Q4 25−3.9%+7.7%Q1 26
0%+5%+10%Q1 25Q2 25Q3 25Q4 25Q1 26
JNJ EPS Trend · estimate vs actualEstimateActual
$0.00$0.80$1.60$2.40$2.58$2.77Q1 25$2.68$2.77Q2 25$2.76$2.80Q3 25$2.46$2.46Q4 25$2.68$2.70Q1 26
$0.00$0.80$1.60$2.40Q1 25Q2 25Q3 25Q4 25Q1 26
JNJ Revenue Trend · estimate vs actualEstimateActual
$0$7.0B$14.0B$21.0B$21.6B$21.9BQ1 25$22.9B$23.7BQ2 25$23.8B$24.0BQ3 25$24.2B$24.6BQ4 25$23.6B$24.1BQ1 26
$0$7.0B$14.0B$21.0BQ1 25Q2 25Q3 25Q4 25Q1 26

Quarter by Quarter

Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2026 $2.70 est. $2.68 +0.85% $24.1B est. $23.6B +1.89%
Q4 2025 $2.46 est. $2.46 −0.19% $24.6B est. $24.2B +1.69%
Q3 2025 $2.80 est. $2.76 +1.49% $24.0B est. $23.8B +1.00%
Q2 2025 $2.77 est. $2.68 +3.43% $23.7B est. $22.9B +3.88%
Q1 2025 $2.77 est. $2.58 +7.34% $21.9B est. $21.6B +1.48%

Figures from SEC filings and company reports. Not investment advice.